Horizon Therapeutics Public Limited Company (HZNP) Stock Analysis
DELISTED
What happened to Horizon Therapeutics Public Limited Company (HZNP) stock?
Horizon Therapeutics Public Limited Company (HZNP) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 51.01 means the share price is 51.01 times one year of earnings per share. Market cap $26.6B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Horizon Therapeutics Public Limited Company (HZNP). Horizon Therapeutics Public Limited Company is a biotechnology firm focused on rare, autoimmune, and severe inflammatory diseases. Their portfolio includes 12 medicines across rare diseases, gout, ophthalmology, and inflammation.
Last analyzed: Mar 16, 2026Horizon Therapeutics Public Limited Company (HZNP) Healthcare & Pipeline Overview
More about this archive record
Can I still buy HZNP shares?
No. HZNP stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for HZNP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HZNP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Horizon Therapeutics Public Limited Company. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.